NorthStar Anesthesia, a leader in anesthesia care delivery nationwide, proudly announces a new partnership with UChicago Medicine AdventHealth Bolingbrook, marking another important expansion in the Chicagoland market. The collaboration is a powerful testament to NorthStar’s proven ability to deliver tailored, high-quality anesthesia services to health systems across the region.
This new engagement, which goes live on April 19, 2025, supports UChicago Medicine AdventHealth Bolingbrook’s strategic move toward implementing a best-in-class anesthesia care team model. In this model, anesthesiologists and Certified Registered Nurse Anesthetists (CRNAs) collaborate closely to provide seamless, safe, and efficient care to patients.
Health Technology Insights: Alberta Cancer Foundation Partners With Cdl Cancer To Advance Oncology Innovation
“We are excited to welcome NorthStar Anesthesia as our new partner,” said Kenneth Rose, CEO of UChicago Medicine AdventHealth Bolingbrook. “This collaboration aligns with our unwavering commitment to providing exceptional, team-based care to our patients, in collaboration with our esteemed surgeons. It also reflects our ongoing investment in clinical excellence and operational efficiency.”
As part of the transition, NorthStar is proud to retain highly respected incumbent physicians to ensure continuity of care and preserve institutional knowledge. The team is also hitting the ground running with the successful hire of a Chief CRNA, a key step in building out the high-performing anesthesia team that patients and providers can rely on.
Health Technology Insights: Chemomab Announces New Medical and Clinical Appointments
“We’re honored to partner with UChicago Medicine AdventHealth Bolingbrook to bring our anesthesia care model to another outstanding health system in Chicagoland,” said Adam Spiegel, CEO of NorthStar Anesthesia. “This expansion is not only a proof point of our momentum in the region, but also of our commitment to innovative, clinician-led solutions that improve outcomes for hospitals, clinicians, and patients alike.”
Both organizations look forward to a long and productive partnership, rooted in a shared dedication to delivering the highest quality care to Bolingbrook and the surrounding community.
Health Technology Insights: JelloX Biotech Establishes US Research Base
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
